Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.
 |
Vidyya |
|
Ars Medica Home |
|
Vidyya Archives |
|
Search Vidyya |
|
Ex Libris |
|
Subscriptions |
|
About Vidyya |
|
|
|
News From The FDA Viagra may soon have a rival for its piece of the multi-billion dollar anti-impotence drug market. Uprima, a sublingual pill made by Abbott Laboratories, has been recommended for FDA approval and may get the green light as soon as July 2000. Read the full report. In other FDA news, Cisapride, a well-known medication for gastroesophageal reflux disease will be taken off the market voluntarily on 14-July-2000. Also, St. John's wort can have extreme adverse effects on patients taking protease inhibitors... |
|
Journal Highlights Nearly 40% of medical practitioners report bending or breaking reimbursement rules to get their patients the treatment they need. Read about the alleged population of admitted rulebreakers and find a full-text link to the April 12, 2000 JAMA article that describes the study in detail. NEJM was so impressed with a recent study from The Acute Respiratory Distress Syndrome Network that they released the findings a month early. Read Vidyya's summary of this important work. |
|
Welcome To Vidyyasm We hope to make the Vidyya newsletter a valuable resource you will use every day. It is our mission to provide our readers with timely, accurate and informative information. |
|
Myths & Misconceptions A great deal of information about vaccinations is available. However, the CDC reports that it has found inaccurate and misleading information published in the medical literature. Be ready for some common misconceptions by reading Six Common Misconceptions About Immunizations |
Ars Medica Home | Ex Libris | Vidyya |
Subscription Information | About Vidyya | Vidyya Archives |
Editor: Susan K. Boyer, RN
© RAmEx Ars Medica, Inc. All rights reserved.